
EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making
15 Apr 2025

New study confirms link between cancer patients’ quality of life and survival
1 Apr 2025

New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial
17 Mar 2025

SISAQOL-IMI consortium launches final recommendations
6 Feb 2025

World Cancer Day 2025: EORTC’s commitment to older patients
4 Feb 2025

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024

Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024

IMMUcan has completed patient enrolment
12 Nov 2024